Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity, Cancer Research UK
22.6.2020Project iBodies, supported by IOCB Tech and i&i Prague, is focused on developing novel macromolecules designed to fully substitute antibodies in common biochemical methods. Recently, iBodies established a cooperation…
Enantis – first biotechnology spin-off from Masaryk University in Brno
12.5.2020Enantis s.r.o. was founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno, Czech Republic. Project went through long development and its expertise is now based…
Prague startup RIOCATH had recently entered market with its world-unique catheter!
12.5.2020RIOCATH Global, a company established in collaboration with IOCB Tech, has developed a revolutionary type of catheter based on world-unique technology applicable for all tubular medical devices. Since its birth…
LAM-X – light-activated nanomaterials for face-masks and respirators
12.5.2020LAM-X a.s. is the newest company established in cooperation with i&i Prague. It develops light-activated nanomaterials which provide protection from bacteria, viruses and other pathogens. The lead product is a…
iBodies – synthetic antibodies from IOCB
12.5.2020iBodies is a project originated at IMC, IOCB and Charles University, which is currently under a pre-seed incubation. The iBodies team focuses on development of the novel…
Elphogene: non-invasive screening of patients in advanced stages of cancer
12.5.2020Elphogene s.r.o. is a Czech spin-off company that succeeds decades of intensive research performed at Genomac research centre as well as thanks to collaborations with leading oncology centres. Using their…
DIANA Biotechnologies – technology that raised EUR 3M in 3 years
12.5.2020DIANA Biotechnologies started as a project of a PhD. student at IOCB. After less than 3 years of pre-seed incubation it developed into an independent biotech company, with their own…
DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies
12.5.2020One of the first project i&i Prague participated in is Dracen Pharmaceuticals. Dracen itself started as an international science team at the Institute of Organic Chemistry and Biochemistry (IOCB Prague)…
LAM-X a.s. is collaborating with TUL to develop active nanofilters against COVID-19
7.5.2020During COVID-19 crisis we embrace our startups to answer current questions and solve present problems. Our the most recently established startup – LAM-X, a.s. – is not an exception. LAM-X…